152 related articles for article (PubMed ID: 28857306)
1. The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model.
Marcu LG; Marcu D
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28857306
[TBL] [Abstract][Full Text] [Related]
2. In silico modelling of a cancer stem cell-targeting agent and its effects on tumour control during radiotherapy.
Marcu LG; Marcu D
Sci Rep; 2016 Aug; 6():32332. PubMed ID: 27573059
[TBL] [Abstract][Full Text] [Related]
3. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway.
Lim YC; Kang HJ; Kim YS; Choi EC
Eur J Cancer; 2012 Nov; 48(17):3310-8. PubMed ID: 22640830
[TBL] [Abstract][Full Text] [Related]
4. [All-trans retinoic acid effectively inhibits breast cancer stem cells growth in vitro].
Zeng WG; Hu P; Wang JN; Liu RB
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):89-93. PubMed ID: 23714660
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.
Yao W; Wang L; Huang H; Li X; Wang P; Mi K; Cheng J; Liu H; Gu C; Huang L; Huang J
BMC Cancer; 2020 Apr; 20(1):315. PubMed ID: 32293355
[TBL] [Abstract][Full Text] [Related]
7. Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening.
Goričan L; Gole B; Potočnik U
Cells; 2020 Jul; 9(7):. PubMed ID: 32708734
[TBL] [Abstract][Full Text] [Related]
8. Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation.
Bertrand G; Maalouf M; Boivin A; Battiston-Montagne P; Beuve M; Levy A; Jalade P; Fournier C; Ardail D; Magné N; Alphonse G; Rodriguez-Lafrasse C
Stem Cell Rev Rep; 2014 Feb; 10(1):114-26. PubMed ID: 23955575
[TBL] [Abstract][Full Text] [Related]
9. The role of hypofractionated radiotherapy in the management of head and neck cancer - a modelling approach.
Marcu LG; Marcu D
J Theor Biol; 2019 Dec; 482():109998. PubMed ID: 31493484
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
Nguyen PH; Giraud J; Staedel C; Chambonnier L; Dubus P; Chevret E; Bœuf H; Gauthereau X; Rousseau B; Fevre M; Soubeyran I; Belleannée G; Evrard S; Collet D; Mégraud F; Varon C
Oncogene; 2016 Oct; 35(43):5619-5628. PubMed ID: 27157616
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells.
Sun R; Liu Y; Li SY; Shen S; Du XJ; Xu CF; Cao ZT; Bao Y; Zhu YH; Li YP; Yang XZ; Wang J
Biomaterials; 2015 Jan; 37():405-14. PubMed ID: 25453968
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
[TBL] [Abstract][Full Text] [Related]
13. In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy.
Marcu LG; Marcu D; Filip SM
Cell Prolif; 2016 Jun; 49(3):304-14. PubMed ID: 27079860
[TBL] [Abstract][Full Text] [Related]
14. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma.
Keysar SB; Gomes N; Miller B; Jackson BC; Le PN; Morton JJ; Reisinger J; Chimed TS; Gomez KE; Nieto C; Frederick B; Pronk GJ; Somerset HL; Tan AC; Wang XJ; Raben D; Su TT; Jimeno A
Cancer Res; 2020 Mar; 80(5):1183-1198. PubMed ID: 31911553
[TBL] [Abstract][Full Text] [Related]
16. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review.
Bouriez D; Giraud J; Gronnier C; Varon C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380687
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner.
Karsy M; Albert L; Tobias ME; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2010 Dec; 30(12):4915-20. PubMed ID: 21187470
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
Reid PA; Wilson P; Li Y; Marcu LG; Bezak E
Head Neck; 2017 Sep; 39(9):1920-1932. PubMed ID: 28644558
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
